This medicine belongs to the class of tyrosine kinase inhibitors. Medical research and clinical studies support Pazopanib 400mg uses for kidney cancer including advanced renal cell carcinoma. It is often used as first line medication for slowing down the progression of the disease.
Overview
- Condition: New
Leave feedback about this